Markets:

Overview

News

Currencies

International

Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

9.580 -0.530 (-5.24%)

Streaming Delayed Price Updated: 11:50 AM EST, Mar 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

66 67 Next >

Novavax's Experimental COVID-19-Influenza Combo Shot Shows Immune Response Among Older Adults In Phase 3 Trial ↗

June 11, 2025

Novavax's combo and standalone flu vaccines showed strong immune responses and good safety in a Phase 3 trial of adults 65 and older.

Via Benzinga

Novavax’s Covid-Flu Combo, Standalone Flu Vaccines Demonstrate Robust Immune Response In Late-Stage Trial: Retail Says It’s ‘A Very Good Sign’ ↗

June 11, 2025

Both candidates were well tolerated, with nearly all adverse events identified as mild or moderate.

Via Stocktwits

American Pharmacists Association Withholds Endorsement Of CDC's Revised COVID-19 Vaccine Guidance ↗

June 10, 2025

The American Pharmacists Association announced Monday it will withhold endorsement of the CDC's updated immunization schedule.

Via Benzinga

Vaccine Stocks Alert: Has RFK Jr.'s CDC Panel Shakeup Sent Retail Traders To The Sidelines? ↗

June 10, 2025

Kennedy said the Department of Health and Human Services would retire all 17 current members of the ACIP, citing what he called a "crisis of public trust."

Via Stocktwits

Topics Government

Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr. ↗

June 09, 2025

A CDC committee in charge of making vaccine recommendations was gutted Monday to make way for a new coalition.

Via Investor's Business Daily

Topics Government

RFK Jr. Champions 'Medical Freedom' While Curtailing Access, Say Public Health Experts ↗

June 06, 2025

U.S. Health Secretary Robert F. Kennedy Jr. has championed "medical freedom" while simultaneously limiting access to COVID-19 vaccines and restricting food stamp purchases, creating what public health...

Via Benzinga

Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals ↗

June 02, 2025

Moderna's mNexspike COVID vaccine approved by FDA for older adults and at-risk groups after Phase 3 trial shows improved efficacy and safety profile.

Via Benzinga

RFK Jr. Drops COVID Vaccine Recommendation For Healthy Kids, But Experts Warn Of Major Risks ↗

May 30, 2025

The U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced the Centers for Disease Control and Prevention will no longer recommend COVID-19 vaccines for healthy children and pregnant...

Via Benzinga

Trump Administration Terminates $590 Million Moderna Bird Flu Vaccine Deal, Dismantling Biden-Era Pandemic Preparedness Effort ↗

May 29, 2025

The Trump administration terminated a nearly $600 million award to Moderna for developing an mRNA-based bird flu vaccine, ending a key Biden-era pandemic preparedness initiative. The cancellation...

Via Benzinga

Topics Government

Robert F. Kennedy Jr. Says CDC Drops COVID Vaccine For 'Healthy' Pregnant Women, Children ↗

May 27, 2025

RFK Jr. says the COVID-19 vaccine is no longer on the CDC's recommended schedule for healthy kids and pregnant women, though the official site still shows it listed.

Via Benzinga

Analysts Think These Stocks Could More Than Double in Value

May 23, 2025

Septerna, Intellia, and Novavax have garnered investor attention for their significant upside potential, but investors should beware the risks as well.

Via MarketBeat

Topics World Trade

What's Driving the Market Sentiment Around Novavax? ↗

May 21, 2025

Via Benzinga

FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr. ↗

May 21, 2025

The U.S. Food and Drug Administration has announced significant changes to COVID-19 vaccine requirements, limiting annual booster approvals to older and high-risk Americans while implementing stricter...

Via Benzinga

FDA Sets New Guidelines For Approving COVID-19 Booster Shots In Healthy Individuals: Moderna, Novavax Stocks Rise ↗

May 20, 2025

The agency plans to demand stronger evidence of efficacy for the shots before approval is granted for healthy persons, between the ages of six months and 64 years, with no risk factors for severe...

Via Stocktwits

The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped. ↗

May 20, 2025

The new framework limits future Covid shots to people age 65 and older and those six months and older with a risk factor for serious illness.

Via Investor's Business Daily

Topics Bankruptcy Government

US Stocks Likely To Open Lower After S&P 500's Six-Day Streak: 'Quick Recoveries Tend To See Stocks Rally More Over The Next 3-12 Months,' Says Expert ↗

May 20, 2025

U.S. stock futures were slightly lower on Tuesday after ending largely flat on Monday. Futures of major benchmark indices were trading lower in premarket.

Via Benzinga

Topics Stocks

Dow Surges Over 100 Points Despite Moody's US Downgrade: Fear Index Remains In 'Greed' Zone ↗

May 20, 2025

Via Benzinga

Topics Stocks

Stocks Mixed, Treasury Bonds Slip On Moody's US Downgrade: What's Driving Markets Monday? ↗

May 19, 2025

U.S. stocks trimmed early-session losses by midday Monday, as investors showed limited concern after Moody's downgraded U.S. sovereign credit from Aaa to Aa1, effectively stripping the world's largest...

Via Benzinga

Topics Economy

Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higher ↗

May 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 19, 2025

Via Benzinga

Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment ↗

May 19, 2025

Novavax's COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milestone payment. Commercial distribution planned for fall.

Via Benzinga

Gapping stocks in Monday's session ↗

May 19, 2025

Let's have a look at what is happening on the US markets on Monday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

CI&T, Novavax, Paramount Group And Other Big Stocks Moving Higher On Monday ↗

May 19, 2025

Via Benzinga

Novavax Stock Rips Nearly 20% Pre-Market After FDA Approves Its COVID-19 Vaccine Nuvaxovid ↗

May 19, 2025

Novavax CEO John C. Jacobs called the approval a “significant milestone” as the company seeks to make its protein-based COVID-19 vaccine commercially available.

Via Stocktwits

Topics Government Stocks

These stocks are moving in today's pre-market session ↗

May 19, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

May 19, 2025

Via Benzinga

US Stocks Likely To Open Lower After Moody's Downgrade: 'Bear Market Isn't Fully Recovered Yet, But It Is Close,' Says Expert ↗

May 19, 2025

U.S. stock futures dipped on Monday after closing higher for the day and the week on Friday. Futures were trading lower in premarket.

Via Benzinga

Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety Scrutiny ↗

May 19, 2025

The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.'s COVID-19 vaccine, restricting its use to people 65 and older and those 12 and up with underlying health conditions...

Via Benzinga

Novavax Wins FDA Approval For COVID-19 Vaccine: Retail Calls For Buyback And Bigger Moves ↗

May 18, 2025

The pharma company secured FDA clearance to manufacture and distribute its COVID-19 vaccine Nuvaxovid for adults and at-risk groups, with no advisory committee hurdles.

Via Stocktwits

Benzinga Bulls And Bears: IBM, Novavax, Arm Holdings — And UK Trade Deal Boosts Markets ↗

May 10, 2025

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

66 67 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.